An oral bacterial lysate for the prevention of recurrent infections of the respiratory tract. Results of a double-blind placebo controlled 6 months study in 342 patients

A preparation of 7 bacteria, playing a dominant role in bronchial infections, has been developed as the oral immune modulator LW 50020 for the prevention and therapy of recurrent infections of the upper and lower respiratory tract.